Child Mortality Clinical Trial
— HCUMOfficial title:
Scaling Up Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA
Verified date | May 2015 |
Source | University of Calgary |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
The investigators will assess whether in Bushenyi District in southwestern Uganda, a two
year intervention providing comprehensive MNCH programming will:
- Reduce morbidity and mortality for children under five years old and;
- Improve access to maternal health services Compared to a control community without MNCH
intervention?
Hypothesis:
Comprehensive maternal, newborn and child health programming in Bushenyi Distrcit can have a
positive impact on morbidity and mortality for children under five years and will improve
access for women to maternal health services which may lead, in the longer term, to
decreased maternal mortality.
Status | Completed |
Enrollment | 10985 |
Est. completion date | March 2015 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 15 Years and older |
Eligibility |
Inclusion Criteria: - all households living in selected communities; all women 15-49 living in selected communities Exclusion Criteria: none |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Uganda | Mbarara University of Science and Technology | Mbarara |
Lead Sponsor | Collaborator |
---|---|
University of Calgary | Canadian International Development Agency |
Uganda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduced morbidity for children under five years old | 2 years | No | |
Secondary | improved maternal access to health services | proportion of pregnant women who have attended antenatal care four or more times; proportion of women whose most recent delivery was attended by a skilled birth attendant; met need for contraception (CIDA indicator) | 24 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04716712 -
Infant Mortality Reduction by the Mass Administration of Azithromycin
|
Phase 4 | |
Completed |
NCT02943681 -
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
|
N/A | |
Completed |
NCT02233127 -
Birth Cohort in Rahimyar Khan, Pakistan
|
N/A | |
Completed |
NCT03676751 -
MORDOR II Burkina Faso: Longitudinal Trial
|
Phase 4 | |
Completed |
NCT04617626 -
Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire
|
N/A | |
Completed |
NCT03367832 -
South African Paediatric Surgical Outcomes Study (SAPSOS)
|
N/A | |
Recruiting |
NCT00656591 -
Community-Based Interventions for Infant Health in Nepal
|
Phase 1 | |
Recruiting |
NCT04235816 -
Improving Care Through Azithromycin Research for Infants in Africa
|
Phase 3 | |
Recruiting |
NCT05016895 -
REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire
|
N/A |